J AUTOIMMUN 润色咨询

JOURNAL OF AUTOIMMUNITY

出版年份：1988 年文章数：878 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：5.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2021-08-04 医者仁者

    协和医院发的多

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2021-03-13 小小医者

    最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2020-05-06 1501fbca77m

    老牌免疫学杂志！效率高，一审3周，专家意见中肯。

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2017-09-08 cecily1979

    7.64wenqingqing 2011-06-28 发表::
    wenqingqing 2011-06-28 15:56:00 发表:

    wenqingqing 2011-06-28 发表::

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2014-08-30 fensheng1981

    这个杂志要版面费吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2014-04-01 Jim

    The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2011-09-16 匿名用户

    基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1005158, encodeId=a48610051582c, content=协和医院发的多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Aug 04 17:43:09 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947857, encodeId=034194e85740, content=最新IF=6.66分，收录的内容包括自身免疫性疾病研究中的方方面面，基础研究领域包括自身免疫性疾病的机制、免疫学、分子生物学、细胞生物学、遗传学和病毒学；临床研究领域包括风湿病学、皮肤病学、内分泌学、肾脏学、血液学和免疫药理学。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:37:09 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590358, encodeId=2ec9590358fe, content=老牌免疫学杂志！效率高，一审3周，专家意见中肯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=386, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/20/d1cab665d01767eb3bb32df74d495ef4.jpg, createdBy=86962126412, createdName=1501fbca77m, createdTime=Wed May 06 00:00:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546651, encodeId=c77a5466512b, content=7.64<span class="quote">wenqingqing 2011-06-28 发表::<br></span><span class="quote">wenqingqing 2011-06-28 15:56:00 发表:<br></span>, beContent=wenqingqing 2011-06-28 发表:: , objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIm8tJomt9YO8TUibdtDu6OMicjNzqpbYX2aicMicv2skvVkqkW2EKdZ9WnHsUUkCw1e3IrBx3nvaDa1Q/0, createdBy=04181926623, createdName=cecily1979, createdTime=Fri Sep 08 00:00:00 CST 2017, time=2017-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505703, encodeId=aff6505e03b0, content=这个杂志要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=92d5108896, createdName=fensheng1981, createdTime=Sat Aug 30 22:26:00 CST 2014, time=2014-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502118, encodeId=1dd750211891, content=The impact factor for JA is false because it publishes many review articles which increase citations. I never read the papers in JA <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=461, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Jim, createdTime=Tue Apr 01 23:32:00 CST 2014, time=2014-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484450, encodeId=cb92484450f3, content=基本上亞洲的文章會先被拒,點數爬得太快,文章直量參差不齊,被拒後,修改革是改投EMBO J馬上就過了! 根本看了題目跟affilication就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=428, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 16 22:56:00 CST 2011, time=2011-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=483727, encodeId=578c483e273b, content=點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 30 21:43:00 CST 2011, time=2011-07-30, status=1, ipAttribution=)]
    2011-07-30 匿名用户

    點數上升過快，品質不齊，基本上對亞洲投稿者較嚴厲，能上的文章品質會高出許多

    0

共57条页码: 2/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分